PF
GILD icon

Prota Financial’s Gilead Sciences GILD Stock Holding History

Prota Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
4,820
+229
+5% +$30.2K 0.4% 44
2026
Q1 		$640K Buy
4,591
+467
+11% +$65.4K 0.46% 29
2025
Q4 		$506K Buy
+4,124
New +$501K 0.36% 39

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Prota Financial's GILD Position: Q2 2026 in Review

Prota Financial increased its Gilead Sciences (GILD) stake by 5% in Q2 2026, buying an estimated $30.2K and bringing the position to 4,820 shares worth $607K. The position accounts for 0.4% of the portfolio, ranked #44.

Prota Financial first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $640K in Q1 2026. 610 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Prota Financial held 4,820 shares of Gilead Sciences worth $607K as of Q2 2026.
  • Prota Financial bought 229 Gilead Sciences shares in Q2 2026, an estimated $30.2K.
  • Gilead Sciences made up 0.4% of Prota Financial's portfolio in Q2 2026, its #44 holding.
  • Prota Financial first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Prota Financial's Gilead Sciences position peaked at $640K in Q1 2026.
  • 610 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Prota Financial's 13F filing for Q2 2026, filed 7 Jul 2026.